Mukhopadhyay, Asima <br/><br/>
Clinicopathological features of homologous recombination-deficient epithelial ovarian cancers: sensitivity to PARP inhibitors, platinum, and survival.  [electronic resource] 

 -  Cancer research  Nov 2012 
 - 5675-82 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-7445 
<br/><br/><label>Standard No.: </label>10.1158/0008-5472.CAN-12-0324  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carboplatin--administration & dosage<br/>Carcinoma, Ovarian Epithelial<br/>Combined Modality Therapy<br/>DNA Breaks, Double-Stranded<br/>Enzyme Inhibitors--administration & dosage<br/>Female<br/>Homologous Recombination<br/>Humans<br/>Kaplan-Meier Estimate<br/>Middle Aged<br/>Neoplasms, Glandular and Epithelial--drug therapy<br/>Ovarian Neoplasms--drug therapy<br/>Paclitaxel--administration & dosage<br/>Poly(ADP-ribose) Polymerase Inhibitors